ENTRADA THERAPEUTICS INC (TRDA) Stock Earnings Estimates
NASDAQ:TRDA • US29384C1080
11.98 USD
+0.5 (+4.36%)
At close: Feb 25, 2026
11.98 USD
0 (0%)
After Hours: 2/25/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 129.013M | 210.782M 63.38% | 31.797M -84.91% | 38.481M 21.02% | 56.559M 46.98% | -100.00% | 67.32M | 264.18M 292.42% | 229.5M -13.13% | 540.6M 135.56% | 731.34M 35.28% | ||
| EBITDA YoY % growth | -95.35M -90.66% | -321K 99.66% | 50.784M 15,920.56% | -149.649M -394.68% | -215.133M -43.76% | -283.865M -31.95% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -97.25M -90.20% | -3.162M 96.75% | 47.011M 1,586.75% | -170.283M -462.22% | -206.185M -21.08% | -250.174M -21.33% | -260.1M -3.97% | -278.46M -7.06% | -143.055M 48.63% | -228.99M -60.07% | -194.82M 14.92% | -80.58M 58.64% | |
| Operating Margin | N/A | -2.45% | 22.30% | -535.53% | -535.81% | -442.32% | N/A | -413.64% | -54.15% | -99.78% | -36.04% | -11.02% | |
| EPS YoY % growth | -3.02 63.24% | -0.26 91.39% | 1.91 834.62% | -3.87 -302.72% | -4.28 -10.51% | -4.40 -2.80% | 6.18 240.52% | -1.88 -130.36% | 0.05 102.72% | -1.10 -2,260.00% | -1.14 -3.70% | -0.47 58.93% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.17 -4,010.00% | -1.05 -150.04% | -1.12 -7.92% | -1.11 -4.45% | -1.10 5.89% |
| Revenue Q2Q % growth | 11.133M -70.23% | 5.924M -71.18% | 1.72M -11.79% | 2.927M 81.35% | 4.202M -62.26% |
| EBITDA Q2Q % growth | -34.92M -1,562.84% | -27.218M -30.58% | -60.233M -34.24% | N/A | N/A |
| EBIT Q2Q % growth | -47.355M -706.74% | -46.576M -113.75% | -56.597M -20.81% | -56.297M -19.65% | -58.769M -24.10% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.06 -202.86% | -0.96 | -0.10 | -10.55% |
| Q2 2025 Q2Q % growth | -1.04 -167.10% | -0.86 | -0.18 | -20.31% |
| Q1 2025 Q2Q % growth | -0.42 -161.76% | -0.80 | 0.38 | 47.81% |
| Q4 2024 Q2Q % growth | 0.03 110.34% | -0.68 | 0.71 | 104.39% |
| Q3 2024 Q2Q % growth | -0.35 -134.31% | -0.74 | 0.39 | 52.87% |
| Q2 2024 Q2Q % growth | 1.55 298.72% | 0.15 | 1.40 | 948.01% |
| Q1 2024 Q2Q % growth | 0.68 423.81% | -0.61 | 1.29 | 212.23% |
| Q4 2023 Q2Q % growth | -0.29 63.29% | -0.17 | -0.12 | -69.23% |
| Q3 2023 Q2Q % growth | 1.02 227.50% | -0.75 | 1.77 | 235.92% |
| Q2 2023 Q2Q % growth | -0.78 -5.41% | -0.70 | -0.08 | -10.83% |
| Q1 2023 Q2Q % growth | -0.21 69.57% | 0.99 | -1.20 | -121.28% |
| Q4 2022 Q2Q % growth | -0.79 11.24% | -0.84 | 0.05 | 6.31% |
| Q3 2022 Q2Q % growth | -0.80 91.82% | -0.78 | -0.02 | -3.20% |
| Q2 2022 Q2Q % growth | -0.74 | -0.74 | 0.00 | -0.21% |
| Q1 2022 Q2Q % growth | -0.69 | -0.67 | -0.02 | -3.28% |
| Q4 2021 Q2Q % growth | -0.89 | -1.31 | 0.42 | 32.04% |
| Q3 2021 Q2Q % growth | -9.78 | -0.89 | -8.89 | -1,002.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.614M -91.75% | 13.976M | -12.362M | -88.45% |
| Q2 2025 Q2Q % growth | 1.95M -97.94% | 9.844M | -7.894M | -80.19% |
| Q1 2025 Q2Q % growth | 20.558M -65.23% | 10.374M | 10.184M | 98.17% |
| Q4 2024 Q2Q % growth | 37.398M -10.63% | 13.383M | 24.015M | 179.44% |
| Q3 2024 Q2Q % growth | 19.57M -55.25% | 12.567M | 7.003M | 55.73% |
| Q2 2024 Q2Q % growth | 94.694M 421.16% | 46.997M | 47.697M | 101.49% |
| Q1 2024 Q2Q % growth | 59.12M 134.05% | 15.276M | 43.844M | 287.01% |
| Q4 2023 Q2Q % growth | 41.848M | 24.169M | 17.679M | 73.15% |
| Q3 2023 Q2Q % growth | 43.735M | 9.789M | 33.946M | 346.78% |
| Q2 2023 Q2Q % growth | 18.17M | 9.972M | 8.198M | 82.21% |
| Q1 2023 Q2Q % growth | 25.26M | 121.38M | -96.12M | -79.19% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -19.12% | -12.24% | -5.3% | -7.54% |
| Revenue | 0% | 47.36% | -4.4% | -20.57% |